COMPASS THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
COMPASS THERAPEUTICS, INC. (CMPX) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2022-03-18
- COMPASS THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2020-12-31 was $315.00K, a 950.00% increase year-over-year.
- COMPASS THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2020-09-30 was $7.00K.
- COMPASS THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- COMPASS THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2020 was $290.00K, a 417.86% increase from fiscal 2019.
- COMPASS THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2019 was $56.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $0.00 10-K · filed 2022-03-18 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $322.00K derived: sum of 2 quarters · filed 2022-03-18 | $256.00K derived: sum of 3 quarters · filed 2022-03-18 | $290.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$59.00K derived: sum of 2 quarters · filed 2021-11-12 | -$25.00K 10-Q · filed 2021-11-12 | $5.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$32.00K 10-Q · filed 2021-08-16 | -$2.00K derived: sum of 3 quarters · filed 2021-08-16 | -$58.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $34.00K 10-Q · filed 2021-04-30 | $64.00K derived: sum of 2 quarters · filed 2021-04-30 | $8.00K derived: sum of 3 quarters · filed 2021-04-30 | |
| 2019-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | -$26.00K derived: sum of 2 quarters · filed 2021-03-05 | $56.00K 10-K · filed 2021-03-05 | |
| 2019-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $26.00K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $82.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |